With reference to email L/SURV/ONL/PV/RS/2021-2022/1254 dated 13.01.2022, Zim Laboratories has informed that the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that in our opinion would have bearing on the price behavior of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time. The movement in the share price of the company is purely due to market conditions and absolutely market driven and, therefore, the Company is unable to comment on the movement in share price of the Company.
The above information is a part of company’s filings submitted to BSE.
